November Seminar Series Features Johanna Joyce (11.17.21)

The November DCI Seminar Series, to be held on Wednesday, November 17, via Zoom, will feature cancer researcher Johanna Joyce, PhD, a professor in the Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne (Switzerland).

Joyce will present “Exploring and Therapeutically Exploiting the Tumor Micro-environment.”

Joyce's lab focuses on the investigation of the micro-environment in which a tumor arises and the critical influence that non-cancerous immune and stromal cells can have on tumor progression, metastasis and therapeutic response. They have uncovered critical regulatory signals provided by the normal tissue stroma and immune cells to the cancer cells, and determined how these normal cells can be modified by the cancer cells to produce a plethora of factors that enhance tumor malignancy.

A major focus of her lab’s recent research has been to deeply and comprehensively interrogate the immune landscape of brain tumors, and then use this gained knowledge to develop novel strategies to therapeutically target the tumor microenvironment.

Joyce is a committed mentor and advisor to many young researchers and a widely-recognized advocate — in particular for women in cancer research.

Joyce was previously a professor at Weill Cornell Medical School (New York). In 2016, she moved her lab, which was based at Memorial Sloan Kettering Cancer Center (New York), to Switzerland.

Joyce is an award-winning cancer researcher who's been recognized with the Robert Bing Prize, the Cloetta Prize, the Swiss Bridge Award, the American Cancer Society Scholar Award, the Rita Allen Foundation Award, the V Foundation Award, and the Sidney Kimmel Foundation Award, among many others. In 2017, she was elected as a Member of EMBO and a Fellow of the European Academy of Cancer Sciences, and in 2020 she was elected to the AACR Women in Cancer Research Council.

Joyce currently serves on the advisory boards of the CRUK Cambridge Institute and Cancer Center, Cambridge, UK; the IRB Institute, Barcelona, Spain; and the Robert Bosch Center for Tumor Diseases, Stuttgart, Germany. She serves on the editorial boards of Cancer Cell, The Journal of Experimental Medicine, Cell Reports, and Trends in Cancer.

Joyce's lecture begins at 8 a.m. and ends at 9 a.m. The November DCI Seminar Series is presented by the DCI Cancer Biology Research Program and is held in conjunction with Hematology Oncology Grand Rounds.

For more information and to access the Zoom link for this talk, email Joan Lofton, MBA, AGM